Embryonic Stem Cells . Org

Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has licensed an engineered stem cell line from the Buck Institute for Age Research. The stem cell line is used in the study of neural cells in neurodegenerative disease. The financial terms were not disclosed.

Read More

Facing a human egg shortage they say is preventing medical breakthroughs, scientists and biotech entrepreneurs are pushing the country’s top funders of stem cell research to rethink rules that prohibit paying women for eggs.

Read More

Drug company GlaxoSmithKline is setting up a US$25-million, five-year collaboration with the Harvard Stem Cell Institute in Cambridge, Massachusetts. The money will support research as well as a staff exchange programme between the two partners.

Read More

U Health Sciences Center researchers hope a new stem cell study will help patients recover from an intense leg disease, which can lead to amputation if it goes unchecked. As a professor and chief of vascular surgery at the U School of Medicine, Larry Kraiss is part of a nationwide trial to see if patients’ own stem cells will help them recover from a type of peripheral vascular disease.

Read More

Specifically, the solution is growing new muscle cells (recapitulating embryonic myogenesis) within the heart (cardiomyoplasty) via stem cells. This would, in effect, deliver a brand-new heart. At the same time, this will reline the …

Read More

An embryonic stem cell is at a state that it can make a whole organism. You can make a whole mouse out of an embryonic stem cell. There are 220 cells in the human body, and embryonic stem cells can make each and every one of them. …

Read More

trying to cultivate platelets from embryonic stem cells (ESCs). Until now, two obstacles have stood in the way of stem cell derived platelets. First, platelets from ESCs are often crowded out by other cells produced by the stem cells. …

Read More

Furthermore, new technologies emerged to produce pluripotent cells without the ethical and immunological drawbacks of embryonic stem cells (for instance by nuclear transfer). Other autologous cell sources are presently under …

Read More

… being spread about stem cells, and you are about to hear a whole lot more. Last week, it became likely that Michigan voters will decide in November whether to get rid of our present policy banning most embryonic stem cell research. …

Read More

Though the debate over federal funding of embryonic stem cell research isn’t as hot of a political topic in this presidential election, part of the reason could be the enormous success of adult stem cells. While embryonic cells still …

Read More